The comparison with TROP2 revealed that EpCAM is less commonly expressed in squamous cell carcinomas but more abundant in most other epithelial neoplasms especially in germ cell tumors, neuroendocrine neoplasms, renal cell tumors, and in gastrointestinal adenocarcinomas. This evidence concerns the gene TACSTD2 and squamous cell carcinoma.